Search
Now showing items 1-1 of 1
Original Research Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial
Peuker, Caroline A. et al. (2022)
Wissenschaftlicher Artikel